166 related articles for article (PubMed ID: 5097219)
1. [Evaluation of clofibrate therapy in peripheral arteriopathy].
Begg TB; Rifkind BM
Minerva Med; 1971 Sep; 62(72):3469-75. PubMed ID: 5097219
[No Abstract] [Full Text] [Related]
2. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
Dotti GC
Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
[No Abstract] [Full Text] [Related]
3. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
Poleszak J; Korolko A
Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
[No Abstract] [Full Text] [Related]
4. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Valiensi M; Riboli E; Lombardi M
Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
[No Abstract] [Full Text] [Related]
5. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
Coscia M
Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
[No Abstract] [Full Text] [Related]
6. Platelet stickiness and serum cholesterol levels after myocardial infarction treated with clofibrate and heparine.
Kusá O
Acta Univ Carol Med Monogr; 1972; 53():413-6. PubMed ID: 4670747
[No Abstract] [Full Text] [Related]
7. Cholesterol, coronaries, clofibrate and death.
Oliver MF
N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204
[No Abstract] [Full Text] [Related]
8. [Treatment of peripheral arterial insufficiency with inositol nicotinate (Hexanicit)].
Hentzer E
Nord Med; 1966 Sep; 76(38):1090-3. PubMed ID: 5918550
[No Abstract] [Full Text] [Related]
9. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Grzegorczyn S
Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):700-3. PubMed ID: 1669136
[TBL] [Abstract][Full Text] [Related]
10. Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.
Postlethwaite JC; Dormandy JA
Ann Surg; 1975 Jun; 181(6):799-802. PubMed ID: 1138629
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacotherapeutical action on arteriosclerotic vascular diseases with benzarone (author's transl)].
Mörl H; Diehm C; Zimmermann R; Schöffel G; Walter E
MMW Munch Med Wochenschr; 1980 Feb; 122(8):277-80. PubMed ID: 6767967
[TBL] [Abstract][Full Text] [Related]
12. The effect of clofibrate on serum and faecal lipids.
Mitchell WD; Murchison LE
Clin Chim Acta; 1972 Jan; 36(1):153-61. PubMed ID: 5007696
[No Abstract] [Full Text] [Related]
13. [On the therapy of central and peripheral blood circulation disorders].
Weihrauch H
Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid].
Silingardi V; Renzi R; Mora A; Di Prisco AU
Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721
[No Abstract] [Full Text] [Related]
15. [The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
Marigo S
Clin Ter; 1980 Jun; 93(5):503-18. PubMed ID: 7428314
[No Abstract] [Full Text] [Related]
16. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
Rugginenti
Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
[No Abstract] [Full Text] [Related]
17. [Myocardial infarct and clofibrate--again].
Werkö L
Lakartidningen; 1978 Nov; 75(48):4458. PubMed ID: 723325
[No Abstract] [Full Text] [Related]
18. [Effects of clofibrate, Isopharm, on fat tolerance in atherosclerotic patients].
Passowicz L
Pol Tyg Lek; 1972 Jul; 27(30):1163-6. PubMed ID: 5073024
[No Abstract] [Full Text] [Related]
19. [Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
Fabre J; Denizot M; Wildi E; Micheli H; Berthoud S
Schweiz Rundsch Med Prax; 1973 Jun; 62(23):732-7. PubMed ID: 4705828
[No Abstract] [Full Text] [Related]
20. [Value of lipid lowering drugs after myocardial infarction: results of the coronary drug project 1975 (author's transl)].
Dubach UC
Schweiz Rundsch Med Prax; 1975 Sep; 64(37):1167-8. PubMed ID: 1219703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
